ois retina 23 mobile header
MicrosoftTeams-image (433)

2023 SPEAKERS

Robert Avery

Robert L. Avery, MD

California Retina Consultants

Caroline Baumal, MD

Apellis / New England Eye Center, Tufts Medical Center
Maria Beroccal MD

Maria Berrocal, MD

Berrocal & Associates

Paul Bresge

Ray Therapeutics

Lori-Ann Christie, PhD

Visionary Venture Fund

Thomas Ciulla, MD, MBA

Indiana University School of Medicine / Midwest Eye Institute

Anupam Dalal, MD

Acuta Capital Partners

Pravin U. Dugel, MD

Iveric Bio
David Esposito

David Esposito

ONL Therapeutics

Paul Hallen

Alcon
Mark-Humayun

Mark Humayun, MD, PhD

University of Southern California Roski Eye Institute
Peter Kaiser, MD

Peter Kaiser, MD

Cole Eye Institute
Baruch Kupperman

Baruch Kuppermann, MD, PhD

University of California
Anat Loewenstein

Anat Loewenstein, MD

Tel Aviv Medical Center / Medical School, Tel Aviv University
Andrew Moshfeghi, MD, MBA

Andrew Moshfeghi, MD, MBA

University of Southern California

James C. Murray

ExSight Ventures
Michael O’Rourke

Michael O’Rourke

Revana Therapeutics

John S. Pollack, MD

Illinois Retina Associates / jCyte
Firas M. Rahhal, MD

Firas M. Rahhal, MD

ExSight Ventures & Retina Vitreous Associates Medical Group
David Sarraf, MD

David Sarraf, MD

Stein Eye Institute at UCLA

Nadia Waheed, MD

Tufts University School of Medicine